Wiki source code of Clinical trials
Last modified by Sarantis Dimitriadis on 2022/06/01 17:48
Show last authors
| author | version | line-number | content |
|---|---|---|---|
| 1 | (% class="western" lang="en-GB" style="text-align:justify" %) | ||
| 2 | (% lang="en-US" style="line-height:107%" %)**Description: **Clinical trials are experiments or observations done to evaluate the effectiveness and safety of new solution by monitoring its effects on large groups of people. Subjects are typically divided into two or more groups, one having “real treatment” by using the developed solution and the other group(s) using tried-and-true solution or not using any solution. The results are compared between the groups to evaluate the impacts. | ||
| 3 | |||
| 4 | (% class="western" lang="en-GB" style="text-align:justify" %) | ||
| 5 | (% lang="en-US" style="line-height:107%" %)**R&D service category-ies: **Testing and validation | ||
| 6 | |||
| 7 | (% class="western" lang="en-GB" style="text-align:justify" %) | ||
| 8 | (% lang="en-US" style="line-height:107%" %)**Key characteristics in Living Lab context:** | ||
| 9 | |||
| 10 | * ((( | ||
| 11 | (% lang="en-GB" style="text-align:justify" %) | ||
| 12 | (% lang="en-US" style="line-height:107%" %)Clinical trials are similar to impact assessment and validation test activities but follow more strict validation and approval process. | ||
| 13 | ))) | ||
| 14 | |||
| 15 | (% class="western" lang="en-GB" style="text-align:justify" %) | ||
| 16 | (% lang="en-US" style="line-height:107%" %)**Participants’ role:** | ||
| 17 | |||
| 18 | * ((( | ||
| 19 | (% lang="en-GB" style="text-align:justify" %) | ||
| 20 | (% lang="en-US" style="line-height:107%" %)Customers as co-creators | ||
| 21 | ))) | ||
| 22 | |||
| 23 | (% class="western" lang="en-GB" style="text-align:justify" %) | ||
| 24 | **Objectives** | ||
| 25 | |||
| 26 | * (% lang="en-US" style="line-height:107%" %)To find out if new solutions are safe and effective | ||
| 27 | * (% lang="en-US" style="line-height:107%" %)Get official approval for new solution | ||
| 28 | |||
| 29 | (% class="western" lang="en-GB" style="text-align:justify" %) | ||
| 30 | (% lang="en-US" style="line-height:107%" %)**Methods:** | ||
| 31 | |||
| 32 | * ((( | ||
| 33 | (% lang="en-GB" style="text-align:justify" %) | ||
| 34 | (% lang="en-US" style="line-height:107%" %)Has multiple phases and classes which depend on the developed solution | ||
| 35 | ))) |